Showing posts with label Pharma Accounting. Show all posts
Showing posts with label Pharma Accounting. Show all posts
Tuesday, June 16, 2009
Lilly China adds to staff
According to China Daily, Pharma giant Lilly China will begin to add nearly 2,000 positions to its company, including accounting and R&D. Read more about Lilly China and the other companies planning to grow their Pharma companies here.
Monday, May 18, 2009
Are CFO’s confused over IFRS?
Dennis Howlett writes, there’s a lot of talk about IFRS implementation in the US but the survey results suggest there is a significant amount of eduction to be delivered. If professionals are unclear about the requirements or its impact, it’s almost impossible for them to form an opinion as to the appropriateness of its application.
The survey that Howlett refers to was from a Grant Thornton study on attitudes to IFRS, the particular excerpt can be found on Howlett's post here.
Read Howlett's entire article by clicking here.
The survey that Howlett refers to was from a Grant Thornton study on attitudes to IFRS, the particular excerpt can be found on Howlett's post here.
Read Howlett's entire article by clicking here.
Labels:
Dennis Howlett,
Grant Thorton study,
IFRS,
Pharma Accounting
Friday, May 15, 2009
The future for US accounting
In a recent report at WebCPA, they look at the current push to have the USA transition from the GAAP accounting system to IFRS. Industry leaders and accounts are currently calling for a more certainty in the transition between the two. Another roadblock may be the views of Mary L. Schapiro on the plan of adoptoin of the new system.
D.J. Gannon, national leadership partner at Deloitte & Touche’s IFRS Center of Excellence, stated:
“They want certainty. Five to seven years is sufficient time for most people to get through what they have to get through.”
Read the full article here.
D.J. Gannon, national leadership partner at Deloitte & Touche’s IFRS Center of Excellence, stated:
“They want certainty. Five to seven years is sufficient time for most people to get through what they have to get through.”
Read the full article here.
Subscribe to:
Posts (Atom)

